A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a C. muridarum challenge

Ítems similars

• Increased immuno accessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with C. muridarum
  per: Tifrea, Delia F., et al.
  Publicat: (2014)
• A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors
  per: Cheng, Chunmei, et al.
  Publicat: (2011)
• Vaccination with the recombinant major outer membrane protein elicits long-term protection in mice against vaginal shedding and infertility following a Chlamydia muridarum genital challenge
  per: Pal, Sukumar, et al.
  Publicat: (2020)
• Protection against a chlamydial respiratory challenge by a chimeric vaccine formulated with the Chlamydia muridarum major outer membrane protein variable domains using the Neisseria lactamica porin B as a scaffold
  per: Tifrea, Delia F., et al.
  Publicat: (2020)
• Vaccination with the Recombinant Major Outer Membrane Protein Elicits Antibodies to the Constant Domains and Induces Cross-Serovar Protection against Intranasal Challenge with Chlamydia trachomatis
  per: Tifrea, Delia F., et al.
  Publicat: (2013)